Page last updated: 2024-09-03

parecoxib and Endometriosis

parecoxib has been researched along with Endometriosis in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Gu, Y; Körbel, C; Laschke, MW; Menger, MD; Nenicu, A	1
Abrao, MS; Alves, LM; Berardo, PT; Fernandes, PD; Landgraf, RG; Machado, DE; Nasciutti, LE; Palmero, C	1

Other Studies

2 other study(ies) available for parecoxib and Endometriosis

Article	Year
Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions. British journal of pharmacology, 2017, Volume: 174, Issue:16 Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Caspase 3; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Therapy, Combination; Endometriosis; Female; Isoxazoles; Matrix Metalloproteinase 9; Mice, Inbred C57BL; PPAR gamma; Proto-Oncogene Proteins c-akt; Telmisartan; Ultrasonography	2017
A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model. Fertility and sterility, 2010, May-15, Volume: 93, Issue:8 Topics: Angiogenesis Inhibitors; Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Endometriosis; Female; Isoxazoles; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2	2010

Article

Year

Combination therapy with telmisartan and parecoxib induces regression of endometriotic lesions.

British journal of pharmacology, 2017, Volume: 174, Issue:16

Topics: Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Benzoates; Caspase 3; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Drug Therapy, Combination; Endometriosis; Female; Isoxazoles; Matrix Metalloproteinase 9; Mice, Inbred C57BL; PPAR gamma; Proto-Oncogene Proteins c-akt; Telmisartan; Ultrasonography

2017

A selective cyclooxygenase-2 inhibitor suppresses the growth of endometriosis with an antiangiogenic effect in a rat model.

Fertility and sterility, 2010, May-15, Volume: 93, Issue:8

Topics: Angiogenesis Inhibitors; Animals; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Disease Models, Animal; Endometriosis; Female; Isoxazoles; Rats; Rats, Sprague-Dawley; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2

2010